Thrombocytopenia induced by imatinib mesylate (Glivec) in patients with chronic myelogenous leukemia: is 400 mg daily of imatinib mesylate an optimal starting dose for Japanese patients?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples